KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-Current Deffered Revenue: 2020-2025

Historic Non-Current Deffered Revenue for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $74.1 million.

  • Ginkgo Bioworks Holdings' Non-Current Deffered Revenue fell 29.62% to $74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.1 million, marking a year-over-year decrease of 29.62%. This contributed to the annual value of $98.8 million for FY2024, which is 37.50% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Non-Current Deffered Revenue stood at $74.1 million for Q3 2025, which was down 0.66% from $74.6 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue registered a high of $179.9 million during Q2 2023, and its lowest value of $60.4 million during Q1 2021.
  • Its 3-year average for Non-Current Deffered Revenue is $130.4 million, with a median of $152.9 million in 2024.
  • In the last 5 years, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue soared by 181.87% in 2022 and then plummeted by 51.60% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Non-Current Deffered Revenue (Quarterly) stood at $156.0 million in 2021, then rose by 12.04% to $174.8 million in 2022, then declined by 9.56% to $158.1 million in 2023, then plummeted by 37.50% to $98.8 million in 2024, then fell by 29.62% to $74.1 million in 2025.
  • Its last three reported values are $74.1 million in Q3 2025, $74.6 million for Q2 2025, and $80.4 million during Q1 2025.